Convalescence
Conditions
Interventions
Experimental group :Ciprofol
Control group:propofol
Sponsors
Clinical Medical College & Affiliated Hospital of Chengdu University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients undergoing anesthesia for elective upper gastrointestinal endoscopy; Aged 18 to 65 years; American Society of Anesthesiologists (ASA) Class I-II.
Exclusion criteria
Exclusion criteria: Patients who are allergic to any planned anesthetic; Patients with allergies to eggs, egg products, soy, or soy products; Patients with contraindications for upper gastrointestinal endoscopy; Patients with liver insufficiency (more than 3 times higher than normal level of liver enzymes) or renal insufficiency (more than 133 µmol/L serum creatinine); Patients with central nervous system diseases or mental disorders; Patients who have received general anesthesia in the past 3 months; Use of anti-anxiety medications and antidepressants in the past 3 months; Patients who are unable to cooperate with the cognitive assessment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Montreal Cognitive Assessment (MoCA); | — |
Secondary
| Measure | Time frame |
|---|---|
| Induction time;Blood pressure;Awaking time of anesthesia;Anesthesia associated complications;Patients' satisfaction; | — |
Countries
China
Contacts
Public ContactLiu Siyuan
Clinical Medical College & Affiliated Hospital of Chengdu University
Outcome results
None listed